Prognostic value of cadherin-associated molecules (α-, β-, and γ- catenins and p120(cas) in bladder tumors

Cancer Research

Volumn 56, Issue 18, 1996, Pages 4154-4158

  Shimazui, Toru ^a,b   Schalken, Jack A ^a,c   Giroldi, Laurence A ^a   Jansen, Cornelius F J ^a   Akaza, Hideyuki ^b   Koiso, Kenkichi ^b   Debruyne, Frans M J ^a   Bringuier, Pierre Paul ^a,d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c UTRECHT UNIVERSITY   (Netherlands)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CATENIN;

ADULT; AGED; ARTICLE; BLADDER TUMOR; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CELL ADHESION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROGNOSIS; UROTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; ALPHA CATENIN; BETA CATENIN; CADHERINS; CELL ADHESION MOLECULES; COMBINED MODALITY THERAPY; CYTOSKELETAL PROTEINS; DESMOPLAKINS; FEMALE; GAMMA CATENIN; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHOSPHOPROTEINS; PROGNOSIS; SURVIVAL RATE; TIME FACTORS; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0029810444     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Heney, N. M , Ahmed, S , Flanagan, M. J., Frable, W., Corder, M. P., Haferman, M. D., and Hawkins, I R Superficial bladder cancer progression and recurrence. J Urol , 130: 1083-1086, 1983
2. Soloway, M. S. Intravesical therapy for bladder cancer. Urol. Clin. North Am., 15, 661-672, 1988.
3. Lipponen, P K. Review of cytometric methods in the assessment of prognosis in transitional cell bladder cancer. Eur Urol , 21 177-183, 1992.
4. Thrasher, J. B., and Crawford, E D. Current management of invasive and metastatic transitional cell carcinoma of the bladder. J Urol , 149: 957-972, 1993.
5. Droller, M. J. Bladder cancer. In: S D Grahm (ed.), Urologic Oncology, pp. 293-321 New York, Raven Press, Ltd , 1986.
6. Prout, G. R., Griffin, P P., and Shipley, W. U Bladder cancer as a systemic disease Cancer (Phila ), 43, 2523-2539, 1979.
7. Giroldi, L A , and Schalken, J. A Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: biological significance and clinical implications. Cancer Metastasis Rev , 12: 29-37, 1993.
8. Birchmeier, W , and Behrens, J. Cadherin expression in carcinomas, role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta, 1198: 11-26, 1994.
9. Bringuier, P. P., Umbas, R., Schaafsma, H. E , Karthaus, H. F. M., Debruyne, F M. J., and Schalken, J. A. Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res., 53: 3241-3245, 1993
10. Nagafuchi, A., and Takeichi, M Cell binding function of E-cadherin is regulated by the cytoplasmic domain. EMBO J., 7: 3679-3684, 1988.
11. Watabe, M., Nagafuchi, A., Tsukita, S , and Takeicht, M. Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J Cell Biol., 127: 247-256, 1994
12. Kawanishi, J., Kato, K., Sasaki, K., Fujii, S., Watanabe, N , and Niitsu, Y. Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the β-catenin gene in a human cancer cell line, HSC-39. Mol. Cell. Biol, 15, 1175-1181, 1995.
13. Kadowaki, T., Shiozaki, H , Inoue, M., Tamura, S., Oka, H , Doki, Y., Iihara, K., Matsui, S., Iwazawa, T. and Nagafuchi, A. E-cadherin and α-catenin expression in human esophageal cancer. Cancer Res , 54: 291-296, 1994.
14. Ochiai, A., Akimoto, S , Shimoyama, Y , Nagafuchi, A., Tsukita, S., and Hirohashi, S. Frequent loss of α-catenin expression in scirrhous carcinomas with scattered cell growth. Jpn. J Cancer Res., 85: 266-273, 1994
15. Rimm, D. L., Sinard, J. H , and Morrow, J S Reduced α-catenin and E-cadherin expression in breast cancer. Lab Invest., 72: 506-512, 1995.
16. cas associates with E-cadherin complex. Mol. Cell. Biol., 14: 8333-8342, 1994.
17. WHO. Histological typing of urinary bladder tumours In: F K. Mostofi, L. H. Sobin, and H. Toroni (eds.), International Histological Classification of Tumours No 10 Geneva: WHO, 1973.
18. Union International Contre Cancer. TNM classification of International Union Against Cancer. In: P. Hermanek and L. H Sabin, TNM Atlas, 4th ed., 3rd revision. Berlin Springer-Verlag, 1992.
19. Frixen, U. H., Behrens, J , Sachs, M., Eberle, G , Voss, B , Warda, A., Lochner, D , and Birchmeier, W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells J. Cell Biol , 113: 173-185, 1991
20. Vleminckx, K , Vakaet, L., Mareel, M , Fiers, W., and van Roy, F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role Cell. 66: 107-119, 1991.
21. Kowalczyk, A. P , Palka, H L., Luu, H H , Nilles., L. A., Anderson, J E., Wheelock, M. J., and Green, K. J Posttranslational regulation of plakoglobin expression J Biol Chem., 269: 31214-31223, 1994
22. Nagafuchi, A., Takeichi, M , and Tsukita, S. The 102-kDa cadherin-associated protein similarity to vinculin and posttranscriptional regulation of expression Cell. 65: 849-857, 1991.
23. cas binds directly to E-cadherin but not to the adenomatous polyposis coli protein or α-catenin Mol Cell. Biol., 15: 4819-4824, 1995.
24. Moll, R , Mitze, M., Frixen, U. H., and Birchmeier, W. Differential loss of E-cadherin expression m infiltrating ductal and lobular breast carcinomas. Am. J. Pathol , 143: 1731-1742, 1993.